Metabolism and surroundings in pancreatic cancer
Treatments studied
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at how the metabolism of pancreatic cancer cells affects their surroundings. It uses a biopsy (removing a small sample of tissue from a tumor in the pancreas, liver, or lung) to learn more about the cancer and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have metastatic pancreatic cancer that needs a biopsy as part of your regular care
- You have not had chemotherapy for this cancer (either for the first time or for a relapse that has spread)
- You are well enough to receive chemotherapy (ECOG score less than 2)
- You are being treated at the Institut Paoli-Calmettes in France
- You are not pregnant, breastfeeding, or under legal guardianship
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced genetic testing on your tumor sample and lab-grown tumor 'organoids' to help pick treatments that may work better for your metastatic pancreatic cancer. The goal is to find a more personalized treatment plan for you.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study looks at advanced or metastatic pancreatic cancer patients and uses stored tumor tissue to learn what may predict treatment outcomes. You may be able to join if you have had limited prior chemotherapy and can provide an archived tissue sample.
This study follows patients with non-metastatic pancreatic cancer that cannot be removed right away. It aims to understand how the disease changes during treatment, which may help improve future care.
This study looks at blood and stool samples from people with advanced pancreatic cancer to understand how their body's metabolism and gut bacteria affect their disease and treatment. It aims to find better ways to predict and improve treatment outcomes.
Hear when a new Pancreatic Adenocarcinoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.